
LTR Pharma increases ownership in LevOmega to ~43% through strategic A$1m investment
LTR Pharma has announced that it has increased its ownership in LevOmega Pty Ltd from 33% to approximately 43%. Through its wholly owned subsidiary, LTR Spectrum Pty Ltd, LTR Pharma has invested A$1.0 million to support the advancement of LevOmega’s research and development programs. LevOmega was co-founded by LTR Pharma,